EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

5α-androstane-3α,17β-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling

Mikhail G Dozmorov, Qing Yang, Adam Matwalli, Robert E Hurst, Daniel J Culkin, Bradley P Kropp, Hsueh-Kung Lin

Genomic Medicine · 2007

DOI: 10.1007/s11568-008-9018-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genomic Medicine, 2007. Verfasst von Mikhail G Dozmorov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Oklahoma Health Sciences Center, 800 Research Parkway, Room 462, Oklahoma City, OK, 73104, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NIDDK NIH HHS.

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

5α-Androstane-3α,17β-diol (3α-diol) is reduced from the potent androgen, 5α-dihydrotestosterone (5α-DHT), by reductive 3α-hydroxysteroid dehydrogenases (3α-HSDs) in the prostate. 3α-diol is recognized as a weak androgen with low affinity toward the androgen receptor (AR), but can be oxidized back to 5α-DHT. However, 3α-diol may have potent effects by activating cytoplasmic signaling pathways, stimulating AR-independent prostate cell growth, and, more importantly, providing a key signal for androgen-independent prostate cancer progression. A cancer-specific, cDNA-based membrane array was used to determine 3α-diol-activated pathways in regulating prostate cancer cell survival and/or proliferation. Several canonical pathways appeared to be affected by 3α-diol-regulated responses in LNCaP cells; among them are apoptosis signaling, PI3K/AKT signaling, and death receptor signaling pathways. Biological analysis confirmed that 3α-diol stimulates AKT activation; and the AKT pathway can be activated independent of the classical AR signaling. These observations sustained our previous observations that 3α-diol continues to support prostate cell survival and proliferation regardless the status of the AR. We provided the first systems biology approach to demonstrate that 3α-diol-activated cytoplasmic signaling pathways are important components of androgen-activated biological functions in human prostate cells. Based on the observations that levels of reductive 3α-HSD expression are significantly elevated in localized and advanced prostate cancer, 3α-diol may, therefore, play a critical role for the transition from androgen-dependent to androgen-independent prostate cancer in the presence of androgen deprivation.

Autor:innen und Institutionen

  • Department of Urology, University of Oklahoma Health Sciences Center, 800 Research Parkway, Room 462, Oklahoma City, OK, 73104, USA.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Dozmorov, M. G., Yang, Q., Matwalli, A., Hurst, R. E., Culkin, D. J., Kropp, B. P., & Lin, H. K. (2007). 5α-androstane-3α,17β-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling. Genomic Medicine. https://doi.org/10.1007/s11568-008-9018-9

Vancouver

Dozmorov MG, Yang Q, Matwalli A, Hurst RE, Culkin DJ, Kropp BP, et al. 5α-androstane-3α,17β-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling. Genomic Medicine. 2007. doi:10.1007/s11568-008-9018-9

BibTeX
@article{Dozmorov2007,
  author = {Dozmorov, Mikhail G and Yang, Qing and Matwalli, Adam and Hurst, Robert E and Culkin, Daniel J and Kropp, Bradley P and Lin, Hsueh-Kung},
  title = {5α-androstane-3α,17β-diol selectively activates the canonical PI3K/AKT pathway: a bioinformatics-based evidence for androgen-activated cytoplasmic signaling},
  journal = {Genomic Medicine},
  year = {2007},
  doi = {10.1007/s11568-008-9018-9}
}
Kostenlos starten →